Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

386148

registered interest
date	29/06/2015
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Public Sector: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, what steps he is taking to support small business access to public procurement.
tabling member constituency	North East Hertfordshire
tabling member printed	Sir Oliver Heald
uin	4522
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>I refer my hon. Friend to the answer I gave to my hon. Friend the Member for Suffolk Central and North Ipswich on 1 July 2015 to UIN 900668.</p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 02/07/2015 12:26:34 answering member 4070 label Biography information for Matt Hancock
tabling member	69 label Biography information for Sir Oliver Heald

386155

registered interest
date	29/06/2015
answering body	Department for Communities and Local Government
answering dept id	7
answering dept short name	Communities and Local Government
answering dept sort name	Communities and Local Government
hansard heading	Planning Permission
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Communities and Local Government, what steps his Department is taking to make viability studies for planning applications more transparent and open to the public and interested stakeholders.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	4517
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>National planning guidance was amended in March 2015 to encourage the speeding up of section 106 negotiations, including promoting greater transparency of viability evidence and of the level of contributions received and how these are used.</p><p> </p><p> </p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 02/07/2015 11:56:20 answering member 4009 label Biography information for Sir Brandon Lewis
tabling member	4368 label Biography information for Neil Coyle

386173

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Meat
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much (a) lamb, (b) beef, (c) pork and (d) poultry meat is purchased annually by the NHS for consumption; and what proportion of such meat is British in origin.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	4515
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>Information on the amount and provenance of all meat purchased by the National Health Service is not held centrally by the Department. However, information is held for fresh meat and poultry purchased through NHS Supply Chain, under national framework agreements.</p><p> </p><p> </p><p> </p><p>Sales of fresh meat and poultry through NHS Supply Chain are estimated as being in the region of 40% of the total for the NHS in England.</p><p> </p><p> </p><p> </p><p>Purchases of fresh meat in the four categories, as requested, are as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p> </p></td><td><p>Value of Purchase £ million</p><p>(July 2013 to June 2014)</p></td><td><p>Percentage that is British in Origin</p></td></tr><tr><td><p>A</p></td><td><p>Lamb</p></td><td><p>1.16</p></td><td><p>60%</p></td></tr><tr><td><p>B</p></td><td><p>Beef</p></td><td><p>3.23</p></td><td><p>92%</p></td></tr><tr><td><p>C</p></td><td><p>Pork</p></td><td><p>1.41</p></td><td><p>57%</p></td></tr><tr><td><p>D</p></td><td><p>Poultry</p></td><td><p>2.49</p></td><td><p>68%</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The information provided relates to sales over the period from July 2013 to June 2014. There have been no significant changes in sourcing over the past 12 months and therefore these proportions will be broadly reflective of the current situation.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/07/2015 12:18:48 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

386174

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to increase the quality and quantity of research into pancreatic cancer.
tabling member constituency	Pudsey
tabling member printed	Stuart Andrew
uin	4525
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health has had no such discussions.</p><p> </p><p> </p><p> </p><p>Expenditure by the Department’s National Institute for Health Research (NIHR) on cancer research is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>A figure for 2014/15 is not yet available. Data is not available for total NIHR research spend on specific cancer sites as site-specific data cannot be disaggregated from total expenditure through NIHR research infrastructure funding streams.</p><p> </p><p> </p><p> </p><p>The NIHR welcomes funding applications for research into any aspect of human health, including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The NIHR has recently awarded £290,986 to University College London Hospitals NHS Foundation Trust for a phase II trial of endoscopic ultrasound-guided radiofrequency ablation of cystic tumours of the pancreas.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service is available to help prospective applicants, including applicants in pancreatic cancer research, develop and design high-quality proposals for submission to NIHR itself and also to other national, peer-reviewed funding competitions for applied health or social care research. The service provides expert advice to researchers on all aspects of preparing grant applications in these fields, including advice on research methodology, clinical trials, patient involvement, and ethics and governance.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 4524 4530 question first answered 02/07/2015 12:13:02 answering member 4020 label Biography information for George Freeman
tabling member	4032 label Biography information for Stuart Andrew

386175

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the adequacy of the level of research funding into pancreatic cancer in each of the last five years; how that figure compares to funding for research on other cancer types; and if he will make a statement.
tabling member constituency	Pudsey
tabling member printed	Stuart Andrew
uin	4524
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health has had no such discussions.</p><p> </p><p> </p><p> </p><p>Expenditure by the Department’s National Institute for Health Research (NIHR) on cancer research is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>A figure for 2014/15 is not yet available. Data is not available for total NIHR research spend on specific cancer sites as site-specific data cannot be disaggregated from total expenditure through NIHR research infrastructure funding streams.</p><p> </p><p> </p><p> </p><p>The NIHR welcomes funding applications for research into any aspect of human health, including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The NIHR has recently awarded £290,986 to University College London Hospitals NHS Foundation Trust for a phase II trial of endoscopic ultrasound-guided radiofrequency ablation of cystic tumours of the pancreas.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service is available to help prospective applicants, including applicants in pancreatic cancer research, develop and design high-quality proposals for submission to NIHR itself and also to other national, peer-reviewed funding competitions for applied health or social care research. The service provides expert advice to researchers on all aspects of preparing grant applications in these fields, including advice on research methodology, clinical trials, patient involvement, and ethics and governance.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 4525 4530 question first answered 02/07/2015 12:13:02 answering member 4020 label Biography information for George Freeman
tabling member	4032 label Biography information for Stuart Andrew

386177

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Mortality Rates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what comparative assessment he has made of variation in the survival rates of pancreatic cancer patients living in (a) the UK, (b) Europe and (c) the rest of the world; and if he will make a statement.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	4529
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>There are some variations in survival rates for pancreatic cancer patients between different countries and different parts of the United Kingdom. We have looked at the international comparisons from EUROCARE 5 – the study of survival and care of cancer patients based on European Cancer Registries - but it can be difficult to interpret survival comparisons for cancers with poor prognosis. Although this only covers patients diagnosed up to 2007, the key issue is that survival rates for pancreatic cancer remain poor – and a challenge to be tackled – across the world.</p><p> </p><p> </p><p> </p><p>We await the final report of the independent Cancer Taskforce, which will make recommendations across the whole cancer care pathway.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 4532 question first answered 02/07/2015 12:07:41 answering member 3918 label Biography information for Jane Ellison
tabling member	4479 label Biography information for Nick Thomas-Symonds

386178

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with Health Ministers in the devolved administrations on increasing research into pancreatic cancer across the UK.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	4530
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health has had no such discussions.</p><p> </p><p> </p><p> </p><p>Expenditure by the Department’s National Institute for Health Research (NIHR) on cancer research is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>A figure for 2014/15 is not yet available. Data is not available for total NIHR research spend on specific cancer sites as site-specific data cannot be disaggregated from total expenditure through NIHR research infrastructure funding streams.</p><p> </p><p> </p><p> </p><p>The NIHR welcomes funding applications for research into any aspect of human health, including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The NIHR has recently awarded £290,986 to University College London Hospitals NHS Foundation Trust for a phase II trial of endoscopic ultrasound-guided radiofrequency ablation of cystic tumours of the pancreas.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service is available to help prospective applicants, including applicants in pancreatic cancer research, develop and design high-quality proposals for submission to NIHR itself and also to other national, peer-reviewed funding competitions for applied health or social care research. The service provides expert advice to researchers on all aspects of preparing grant applications in these fields, including advice on research methodology, clinical trials, patient involvement, and ethics and governance.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 4524 4525 question first answered 02/07/2015 12:13:02 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

386181

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Mortality Rates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what comparative assessment he has made of variations in (a) one, (b) five and (c) 10-year survival rates for pancreatic cancer in each (i) region and (ii) clinical commissioning group; and if he will make a statement.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	4532
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>There are some variations in survival rates for pancreatic cancer patients between different countries and different parts of the United Kingdom. We have looked at the international comparisons from EUROCARE 5 – the study of survival and care of cancer patients based on European Cancer Registries - but it can be difficult to interpret survival comparisons for cancers with poor prognosis. Although this only covers patients diagnosed up to 2007, the key issue is that survival rates for pancreatic cancer remain poor – and a challenge to be tackled – across the world.</p><p> </p><p> </p><p> </p><p>We await the final report of the independent Cancer Taskforce, which will make recommendations across the whole cancer care pathway.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 4529 question first answered 02/07/2015 12:07:41 answering member 3918 label Biography information for Jane Ellison
tabling member	4056 label Biography information for Nic Dakin

386184

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress his Department has made on licencing the Harvoni form of ledipasvir-sofosbuvir for people who have been contaminated by blood products; and if he will make a statement.
tabling member constituency	South Down
tabling member printed	Ms Margaret Ritchie
uin	4569
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>Harvoni (ledipasvir-sofosbuvir) has been authorised by the European Commission and a Marketing Authorisation was issued on 17 November 2014 for the treatment of chronic hepatitis C in adults.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence is currently developing technology appraisal guidance for the National Health Service on the clinical and cost-effectiveness of Harvoni (ledipasvir-sofosbuvir) in the treatment of chronic hepatitis C and expects to publish its final guidance later this year.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/07/2015 12:11:31 answering member 4020 label Biography information for George Freeman
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

386200

registered interest
date	29/06/2015
answering body	Attorney General
answering dept id	88
answering dept short name	Attorney General
answering dept sort name	Attorney General
hansard heading	Crime: Victims
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Attorney General, what steps he is taking to ensure that (a) victim impact statements and (b) compensation claims are made when cases are brought to court in (i) Northamptonshire and (ii) the UK.
tabling member constituency	Kettering
tabling member printed	Mr Philip Hollobone
uin	4706
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p><strong> </strong>a) Under the Code of Practice for Victims of Crime (Victims’ Code), victims are entitled to make a Victim Personal Statement (VPS), (sometimes referred to as a ‘victim impact statement’). When the Code came in to force in December 2013 the Crown Prosecution Service (CPS) issued operational guidance to support prosecutors in meeting their commitments. More recently, a national cross-agency protocol setting out the working arrangements for the reading of the VPS in criminal proceedings has been implemented (the CPS is a signatory).</p><p> </p><p> </p><p> </p><p>b) The CPS has issued legal guidance on the role of the prosecutor to assist the court in the sentencing process by making it aware of all relevant information. This includes drawing the court’s attention to its powers to award compensation and inviting them to make such an order where appropriate.</p><p> </p><p> </p><p> </p><p>Northamptonshire is part of the CPS East Midlands Area and the Area applies the national guidance which has been issued both in respect of the VPS and also compensation claims.</p><p> </p> answering member constituency South Swindon answering member printed Robert Buckland question first answered 02/07/2015 10:59:22 answering member 4106 label Biography information for Sir Robert Buckland
tabling member	1537 label Biography information for Mr Philip Hollobone